ask="23.30"
ask_size="600"
average_daily_volume="413868"
bid="21.50"
bid_size="1000"
book_value="3.21"
change="-0.71"
change_from_200_day_moving_average="7.67"
change_from_50_day_moving_average="2.40"
change_from_52_week_high="-1.56"
change_From_52_week_low="16.65"
change_in_percent="-3.10%"
close="22.19"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.48"
ebitda="-21.87M"
eps_estimate_current_year="-2.59"
eps_estimate_next_quarter="-0.59"
eps_estimate_next_year="-2.48"
ex_dividend_date="N/A"
float_shares="7150000"
high="23.21"
high_52_weeks="23.75"
last_trade_date="3/1/2017"
last_trade_price="22.19"
last_trade_size="15686"
last_trade_time="4:00pm"
low="22.03"
low_52_weeks="5.54"
market_capitalization="220.86M"
moving_average_200_day="14.52"
moving_average_50_day="19.79"
name="Zynerba Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.63"
open="23.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+52.83%"
percent_change_from_50_day_moving_average="+12.13%"
percent_change_from_52_week_high="-6.57%"
percent_change_from_52_week_low="+300.54%"
previous_close="22.90"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.14"
price_per_sales="4032.33"
revenue="56524.00"
shares_outstanding="9953000"
short_ratio="3.02"
stock_exchange="NGM"
symbol="ZYNE"
volume="532906"
weeks_range_52="5.54 - 23.75"
